Metalloinvest received 2,000 doses of vaccine to protect against infections causing bacterial otitis, sore throat, meningitis, and pneumonia.
“In the modern world, the threat to human health is represented not by exotic viruses, but by the most common pneumococci,” explains the head of the department of health protection at Metalloinvest MC Andrei Salnikov. “These pathogens are constantly mutated, less and less vulnerable to most antibiotics, and more and more aggressive. And vaccination is the most civilized way to protect the body, especially in people with weakened immunity.
According to doctors, this drug is the last generation – the most effective and safe vaccine in its group, the most processed and clinically proven. It is shown even to two months old children and the elderly. Its only drawback is the high cost. However, Metalloinvest is sure: the health of workers is the main value of the company.
“First of all, vaccination will be offered to those employees of the plant who have a risk of developing bronchopulmonary diseases,” said Olga Smechnyova, chief specialist of the Lebedinsky GOK health care group. – This measure of prevention will help to effectively reduce the level of occupational diseases, namely, the pathologies of the respiratory system.
A single vaccination will help protect against pneumonia and bronchitis for life.